Back to Journals » Cancer Management and Research » Volume 11
Original Research
Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,868 | Dovepress* | 5,357+ | 761 | 6,118 | |
PubMed Central* | 511 | 182 | 693 | ||
Totals | 5,868 | 943 | 6,811 | ||
*Since 12 December 2019 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar